Drugs / DKK1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03591614 | Dec 2023 → Aug 2024 | monoclonal gammopathy, smoldering plasma cell myeloma | Case Comprehensive Cancer Center | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DKK1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03591614 ↗ |
| Modality | Vaccine | “investigational (experimental) vaccine” NCT03591614 ↗ |